 <h1>Nexium Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>esomeprazole</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about esomeprazole. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Nexium.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to esomeprazole: oral capsule delayed release, oral packet, oral tablet delayed release</i></p><p>Other dosage forms:</p><ul><li>intravenous powder for solution</li></ul><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, esomeprazole (the active ingredient contained in Nexium) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking esomeprazole:</p><p>
<i>Incidence not known</i>
</p><ul>
<li>Blistering, peeling, or loosening of the skin</li>
<li>bloating</li>
<li>chills</li>
<li>constipation</li>
<li>cough</li>
<li>darkened urine</li>
<li>difficulty with swallowing</li>
<li>dizziness</li>
<li>drowsiness</li>
<li>fast heartbeat</li>
<li>fever</li>
<li>indigestion</li>
<li>joint or muscle pain</li>
<li>loss of appetite</li>
<li>mood or mental changes</li>
<li>muscle spasms (tetany) or twitching</li>
<li>nausea</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>red skin lesions, often with a purple center</li>
<li>red, irritated eyes</li>
<li>seizures</li>
<li>skin rash, hives, itching</li>
<li>sore throat</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>tightness in the chest</li>
<li>trembling</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>yellow eyes or skin</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of esomeprazole may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Bad, unusual, or unpleasant (after) taste</li>
<li>change in taste</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Sleepiness or unusual drowsiness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Acne</li>
<li>back pain</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Agitation</li>
<li>dry mouth</li>
<li>excess air or gas in the stomach or bowels</li>
<li>full feeling</li>
<li>hair loss or thinning of the hair</li>
<li>muscular weakness</li>
<li>passing gas</li>
<li>seeing, hearing, or feeling things that are not there</li>
<li>swelling of the breasts or breast soreness in both females and males</li>
<li>swelling or inflammation of the mouth</li>
<li>swollen joints</li>
</ul><p>
<div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to esomeprazole: intravenous powder for injection, oral delayed release capsule, oral delayed release tablet, oral powder for reconstitution delayed release</i></p><h3>General</h3><p>The most frequently occurring adverse reactions were headache and diarrhea.</p>
<p>The most frequently reported adverse reactions for patients who received triple therapy for 10 days were diarrhea, taste perversion, and abdominal pain.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Very Common (10% or more): Headache (up to 10.9%)</p>
<p><b>Common</b> (1% to 10%): Dizziness, somnolence, taste disturbance/perversion, vertigo</p>
<p><b>Uncommon</b> (0.1% to 1%): Paresthesia</p>
<p><b>Very rare</b> (less than 0.01%): Hepatic encephalopathy</p>
<p><b>Frequency not reported</b>: Hypertonia, hypoesthesia, migraine/aggravated migraine, parosmia, taste loss, tremor<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Flatulence (up to 10.3%)</p>
<p><b>Common</b> (1% to 10%): Abdominal pain, benign fundic gland polyps, constipation/constipation aggravated, diarrhea, dry mouth, duodenal ulcer hemorrhage, epigastric pain/aggravated epigastric pain, gastritis/aggravated gastritis, nausea/aggravated nausea, regurgitation, tooth disorder, vomiting/aggravated vomiting</p>
<p><b>Rare</b> (0.01% to 0.1%): Gastrointestinal (GI) candidiasis, stomatitis</p>
<p><b>Very rare</b> (less than 0.01%): Microscopic colitis</p>
<p><b>Frequency not reported</b>: Barrett's esophagus, benign polyps or nodules, bowel irregularity, duodenitis, dyspepsia, dysphagia, dysplasia GI, enlarged abdomen, eructation, esophagitis, esophageal disorder, esophageal stricture, esophageal ulceration, esophageal varices, frequent stools, gastric ulcer, gastroenteritis, GI hemorrhage, GI symptoms not otherwise specified, hernia, hiccup, melena, mouth disorder, mucosal discoloration, pharynx disorder, rectal disorder, tongue disorder, tongue edema, ulcerative stomatitis</p>
<p><b>Postmarketing reports</b>: Clostridium difficile associated diarrhea, fundic gland polyps, hemorrhagic necrotic gastritis (in children), pancreatitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, respiratory infection, sinusitis, tachypnea (in pediatrics)</p>
<p><b>Uncommon</b> (0.1% to 1%): Epistaxis</p>
<p><b>Rare</b> (0.01% to 0.1%): Bronchospasm</p>
<p><b>Frequency not reported</b>: Asthma aggravated, dyspnea, larynx edema, pharyngitis, rhinitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Accident or injury, fever/pyrexia</p>
<p><b>Rare</b> (0.01% to 0.1%): Malaise</p>
<p><b>Frequency not reported</b>: Asthenia, earache, facial edema, fatigue, leg edema, otitis media, pain, rigors, tinnitus<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus</p>
<p><b>Uncommon</b> (0.1% to 1%): Dermatitis, rash, urticaria</p>
<p><b>Rare</b> (0.01% to 0.1%): Alopecia, increased sweating/hyperhidrosis, photosensitivity</p>
<p><b>Very rare</b> (less than 0.01): Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN)/ fatal TEN</p>
<p><b>Frequency not reported</b>: Acne, erythema, pruritus ani, rash erythematous, rash maculo-papular, skin inflammation, subacute cutaneous lupus erythematosus (SCLE)</p>
<p><b>Postmarketing reports</b>: Cutaneous lupus erythematosus, systemic lupus erythematosus<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension/aggravated hypertension</p>
<p><b>Uncommon</b> (0.1% to 1%): Peripheral edema</p>
<p><b>Frequency not reported</b>: Chest pain, flushing, generalized edema/swelling/inflammation, hot flush, hypertension, irregular heartbeat, phlebitis, substernal chest pain, superficial phlebitis, tachycardia, thrombophlebitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>An increased risk of hip fracture has been reported in a cohort study.  The risk was significantly increased among patients prescribed long-term high PPIs.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Back pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Fracture of the hip, wrist or spine</p>
<p><b>Rare</b> (0.01% to 0.1%): Arthralgia, myalgia</p>
<p><b>Very rare</b> (less than 0.01%): Muscular weakness</p>
<p><b>Frequency not reported</b>: Arthritis aggravated, arthropathy, cramps, fibromyalgia syndrome, hernia, hyperuricemia/increased uric acid, polymyalgia rheumatica</p>
<p><b>Postmarketing reports</b>: Bone fracture<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Increased serum gastrin</p>
<p><b>Very rare</b> (less than 0.01%): Gynecomastia</p>
<p><b>Frequency not reported</b>: Decreased/increased thyroxine, goiter, increased thyroid stimulating hormone<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Administration/injection site reactions</p>
<p><b>Postmarketing reports</b>: Tissue inflammatory reaction<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Viral infection</p>
<p><b>Frequency not reported</b>: Flu-like disorder, fungal infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased liver enzymes</p>
<p><b>Rare</b> (0.01% to 0.1%): Hepatitis with/without jaundice</p>
<p><b>Very rare</b> (less than 0.01%): Hepatic failure</p>
<p><b>Frequency not reported</b>: Abnormal hepatic function, AST increased, bilirubinemia, increased alkaline phosphatase, increased total bilirubin<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision</p>
<p><b>Rare</b> (0.01% to 0.1%): Visual accommodation disorder/disturbances, visual field defect</p>
<p><b>Frequency not reported</b>: Abnormal vision, conjunctivitis</p>
<p><b>Postmarketing reports</b>: Irreversible visual impairment, loss of vision<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Insomnia, irritability</p>
<p><b>Rare</b> (0.01% to 0.1%): Agitation, confusion, depression/aggravated depression</p>
<p><b>Very rare</b> (less than 0.01%): Aggression, hallucinations</p>
<p><b>Frequency not reported</b>: Apathy, nervousness, sleep disorder<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Leukopenia, thrombocytopenia</p>
<p><b>Very rare</b> (less than 0.01%): Agranulocytosis, pancytopenia</p>
<p><b>Frequency not reported</b>: Anemia, anemia hypochromic, cervical lymphadenopathy, decreased/increased hemoglobin, decreased/increased platelets, decreased/increased white blood cell count, leukocytosis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (0.01% to 0.1%): Hyponatremia</p>
<p><b>Very rare</b> (less than 0.01%): Hypomagnesemia with or without hypocalcemia and/or hypokalemia, severe hypomagnesemia</p>
<p><b>Frequency not reported</b>: Anorexia, decreased/increased potassium, increased sodium, increased appetite, vitamin B12 (cyanocobalamin) deficiency, thirst, weight decrease/increase<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic reaction/shock, angioedema, hypersensitivity reactions</p>
<p><b>Frequency not reported</b>: Allergic reaction<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Interstitial nephritis with/without renal failure</p>
<p><b>Frequency not reported</b>: Glycosuria</p>
<p><b>Postmarketing reports</b>: Acute interstitial nephritis, impaired renal function, increased creatinine, nephrosis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Abnormal urine, albuminuria, cystitis, dysmenorrhea, dysuria, genital moniliasis, hematuria, impotence, menstrual disorder, micturition frequency, moniliasis, polyuria, vaginitis<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Nexium (esomeprazole)" Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_3">3. "Product Information. NexIUM I.V. (esomeprazole)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_4">4. "Product Information. Esomeprazole Strontium (esomeprazole)." Amneal Pharmaceuticals, Glasgow, KY. </p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>Nexium vs Prilosec: What's the difference between them?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Nexium (esomeprazole)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>169 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: proton pump inhibitors</li>
<li>FDA Alerts (5)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nexium Oral &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Nexium I.V.</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Barrett's Esophagus</li>
<li>GERD</li>
<li>Erosive Esophagitis</li>
<li>Duodenal Ulcer Prophylaxis</li>
<li data-more-config-id="list-data-resources-conditions">... +4 more</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to esomeprazole: intravenous powder for injection, oral delayed release capsule, oral delayed release tablet, oral powder for reconstitution delayed release</i></p><h3>General</h3><p>The most frequently occurring adverse reactions were headache and diarrhea.</p><p>The most frequently reported adverse reactions for patients who received triple therapy for 10 days were diarrhea, taste perversion, and abdominal pain.<sup>[Ref]</sup></p><h3>Nervous system</h3><p>Very Common (10% or more): Headache (up to 10.9%)</p><p><b>Common</b> (1% to 10%): Dizziness, somnolence, taste disturbance/perversion, vertigo</p><p><b>Uncommon</b> (0.1% to 1%): Paresthesia</p><p><b>Very rare</b> (less than 0.01%): Hepatic encephalopathy</p><p><b>Frequency not reported</b>: Hypertonia, hypoesthesia, migraine/aggravated migraine, parosmia, taste loss, tremor<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Flatulence (up to 10.3%)</p><p><b>Common</b> (1% to 10%): Abdominal pain, benign fundic gland polyps, constipation/constipation aggravated, diarrhea, dry mouth, duodenal ulcer hemorrhage, epigastric pain/aggravated epigastric pain, gastritis/aggravated gastritis, nausea/aggravated nausea, regurgitation, tooth disorder, vomiting/aggravated vomiting</p><p><b>Rare</b> (0.01% to 0.1%): Gastrointestinal (GI) candidiasis, stomatitis</p><p><b>Very rare</b> (less than 0.01%): Microscopic colitis</p><p><b>Frequency not reported</b>: Barrett's esophagus, benign polyps or nodules, bowel irregularity, duodenitis, dyspepsia, dysphagia, dysplasia GI, enlarged abdomen, eructation, esophagitis, esophageal disorder, esophageal stricture, esophageal ulceration, esophageal varices, frequent stools, gastric ulcer, gastroenteritis, GI hemorrhage, GI symptoms not otherwise specified, hernia, hiccup, melena, mouth disorder, mucosal discoloration, pharynx disorder, rectal disorder, tongue disorder, tongue edema, ulcerative stomatitis</p><p><b>Postmarketing reports</b>: Clostridium difficile associated diarrhea, fundic gland polyps, hemorrhagic necrotic gastritis (in children), pancreatitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Cough, respiratory infection, sinusitis, tachypnea (in pediatrics)</p><p><b>Uncommon</b> (0.1% to 1%): Epistaxis</p><p><b>Rare</b> (0.01% to 0.1%): Bronchospasm</p><p><b>Frequency not reported</b>: Asthma aggravated, dyspnea, larynx edema, pharyngitis, rhinitis<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Accident or injury, fever/pyrexia</p><p><b>Rare</b> (0.01% to 0.1%): Malaise</p><p><b>Frequency not reported</b>: Asthenia, earache, facial edema, fatigue, leg edema, otitis media, pain, rigors, tinnitus<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Common</b> (1% to 10%): Pruritus</p><p><b>Uncommon</b> (0.1% to 1%): Dermatitis, rash, urticaria</p><p><b>Rare</b> (0.01% to 0.1%): Alopecia, increased sweating/hyperhidrosis, photosensitivity</p><p><b>Very rare</b> (less than 0.01): Erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis (TEN)/ fatal TEN</p><p><b>Frequency not reported</b>: Acne, erythema, pruritus ani, rash erythematous, rash maculo-papular, skin inflammation, subacute cutaneous lupus erythematosus (SCLE)</p><p><b>Postmarketing reports</b>: Cutaneous lupus erythematosus, systemic lupus erythematosus<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Hypertension/aggravated hypertension</p><p><b>Uncommon</b> (0.1% to 1%): Peripheral edema</p><p><b>Frequency not reported</b>: Chest pain, flushing, generalized edema/swelling/inflammation, hot flush, hypertension, irregular heartbeat, phlebitis, substernal chest pain, superficial phlebitis, tachycardia, thrombophlebitis<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p>An increased risk of hip fracture has been reported in a cohort study.  The risk was significantly increased among patients prescribed long-term high PPIs.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Back pain</p><p><b>Uncommon</b> (0.1% to 1%): Fracture of the hip, wrist or spine</p><p><b>Rare</b> (0.01% to 0.1%): Arthralgia, myalgia</p><p><b>Very rare</b> (less than 0.01%): Muscular weakness</p><p><b>Frequency not reported</b>: Arthritis aggravated, arthropathy, cramps, fibromyalgia syndrome, hernia, hyperuricemia/increased uric acid, polymyalgia rheumatica</p><p><b>Postmarketing reports</b>: Bone fracture<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Common</b> (1% to 10%): Increased serum gastrin</p><p><b>Very rare</b> (less than 0.01%): Gynecomastia</p><p><b>Frequency not reported</b>: Decreased/increased thyroxine, goiter, increased thyroid stimulating hormone<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Administration/injection site reactions</p><p><b>Postmarketing reports</b>: Tissue inflammatory reaction<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Common</b> (1% to 10%): Viral infection</p><p><b>Frequency not reported</b>: Flu-like disorder, fungal infection<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Common</b> (1% to 10%): ALT increased</p><p><b>Uncommon</b> (0.1% to 1%): Increased liver enzymes</p><p><b>Rare</b> (0.01% to 0.1%): Hepatitis with/without jaundice</p><p><b>Very rare</b> (less than 0.01%): Hepatic failure</p><p><b>Frequency not reported</b>: Abnormal hepatic function, AST increased, bilirubinemia, increased alkaline phosphatase, increased total bilirubin<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Uncommon</b> (0.1% to 1%): Blurred vision</p><p><b>Rare</b> (0.01% to 0.1%): Visual accommodation disorder/disturbances, visual field defect</p><p><b>Frequency not reported</b>: Abnormal vision, conjunctivitis</p><p><b>Postmarketing reports</b>: Irreversible visual impairment, loss of vision<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Insomnia, irritability</p><p><b>Rare</b> (0.01% to 0.1%): Agitation, confusion, depression/aggravated depression</p><p><b>Very rare</b> (less than 0.01%): Aggression, hallucinations</p><p><b>Frequency not reported</b>: Apathy, nervousness, sleep disorder<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Rare</b> (0.01% to 0.1%): Leukopenia, thrombocytopenia</p><p><b>Very rare</b> (less than 0.01%): Agranulocytosis, pancytopenia</p><p><b>Frequency not reported</b>: Anemia, anemia hypochromic, cervical lymphadenopathy, decreased/increased hemoglobin, decreased/increased platelets, decreased/increased white blood cell count, leukocytosis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Rare</b> (0.01% to 0.1%): Hyponatremia</p><p><b>Very rare</b> (less than 0.01%): Hypomagnesemia with or without hypocalcemia and/or hypokalemia, severe hypomagnesemia</p><p><b>Frequency not reported</b>: Anorexia, decreased/increased potassium, increased sodium, increased appetite, vitamin B12 (cyanocobalamin) deficiency, thirst, weight decrease/increase<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Rare</b> (0.01% to 0.1%): Anaphylactic reaction/shock, angioedema, hypersensitivity reactions</p><p><b>Frequency not reported</b>: Allergic reaction<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Very rare</b> (less than 0.01%): Interstitial nephritis with/without renal failure</p><p><b>Frequency not reported</b>: Glycosuria</p><p><b>Postmarketing reports</b>: Acute interstitial nephritis, impaired renal function, increased creatinine, nephrosis<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Frequency not reported</b>: Abnormal urine, albuminuria, cystitis, dysmenorrhea, dysuria, genital moniliasis, hematuria, impotence, menstrual disorder, micturition frequency, moniliasis, polyuria, vaginitis<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. "Product Information. Nexium (esomeprazole)" Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_3">3. "Product Information. NexIUM I.V. (esomeprazole)." Astra-Zeneca Pharmaceuticals, Wilmington, DE. </p><p id="ref_4">4. "Product Information. Esomeprazole Strontium (esomeprazole)." Amneal Pharmaceuticals, Glasgow, KY. </p><p id="ref_5">5. Cerner Multum,  Inc. "Australian Product Information." O 0</p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>Nexium vs Prilosec: What's the difference between them?</li>
</ul><h2>More about Nexium (esomeprazole)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Patient Tips</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Compare Alternatives</li>
<li>Support Group</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>169 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: proton pump inhibitors</li>
<li>FDA Alerts (5)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Nexium Oral &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +2 more</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Nexium I.V.</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Barrett's Esophagus</li>
<li>GERD</li>
<li>Erosive Esophagitis</li>
<li>Duodenal Ulcer Prophylaxis</li>
<li data-more-config-id="list-data-resources-conditions">... +4 more</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>